Intercept Pharmaceuticals Aktie
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Intercept Pharmaceuticals Aktie Analyse
| 06.07.16 | Intercept Pharmaceuticals Sell | Cantor Fitzgerald | |
| 03.12.14 | Intercept Pharmaceuticals Underperform | FBR Capital | |
| 10.11.14 | Intercept Pharmaceuticals Underperform | FBR Capital |
Werbung
Werbung